Gene networks in baboon PBMCs and secondary lymphoid tissues after rSm-p80 + ODN vaccination and S. <i>mansoni</i> challenge. by Juan U. Rojo (3743365)

Complex interaction networks of cytokines after transarterial chemotherapy in patients with hepatocellular carcinoma by Dong Wook Jekarl (6851633)

“…After TACE, IL-1β, -6,-9, -12, and -22 increased by D60. IL-2, -5, -10, -17A and INF-γ decreased by D60, and IL-4, -13 and TNF-α revealed stable concentration. …”

Table_1_Effects of Synbiotics on the Fecal Microbiome and Metabolomic Profiles of Healthy Research Dogs Administered Antibiotics: A Randomized, Controlled Trial.docx by Jacqueline C. Whittemore (9872294)

“…<p>Background: Antibiotic-associated gastrointestinal signs occurred in 100% of dogs administered enrofloxacin with metronidazole in a previous study, and signs partially were mitigated by synbiotics. …”

Average changes in (A) spontaneous AP firing rate, (B) ATP and (C) cAMP by decreasing CaMKII activity with KN-93 (high-3 µmol/L, low-0.5 µmol/L), AIP (high-10 µmol/L, low-2 µmol/L)... by Yael Yaniv (162548)

Supplementary Material for: Cardiorenal Outcomes With Finerenone in Asian Patients With Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD Post Hoc Analysis by Koya D. (16817664)

“…Efficacy outcomes included a primary kidney composite (time to kidney failure, sustained decrease of ≥40% in eGFR from baseline, and death from renal causes) and secondary cardiovascular (time to cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, or hospitalization for heart failure) and kidney (time to kidney failure, sustained decrease of ≥57% in eGFR from baseline, and death from renal causes) composites. …”

Supplementary Material for: Cardiorenal Outcomes With Finerenone in Asian Patients With Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD Post Hoc Analysis by Koya D. (16817664)

“…Efficacy outcomes included a primary kidney composite (time to kidney failure, sustained decrease of ≥40% in eGFR from baseline, and death from renal causes) and secondary cardiovascular (time to cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, or hospitalization for heart failure) and kidney (time to kidney failure, sustained decrease of ≥57% in eGFR from baseline, and death from renal causes) composites. …”

Supplementary Material for: Cardiorenal Outcomes With Finerenone in Asian Patients With Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD Post Hoc Analysis by Koya D. (16817664)

“…Efficacy outcomes included a primary kidney composite (time to kidney failure, sustained decrease of ≥40% in eGFR from baseline, and death from renal causes) and secondary cardiovascular (time to cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, or hospitalization for heart failure) and kidney (time to kidney failure, sustained decrease of ≥57% in eGFR from baseline, and death from renal causes) composites. …”

Supplementary Material for: TGF-β1 Impairs Vitamin D-Induced and Constitutive Airway Epithelial Host Defense Mechanisms by Schrumpf J.A. (3722734)

“…Exposure to TGF-β1 reduced both baseline and VD-induced expression of hCAP18/LL-37, partly by increasing the expression of the VD-degrading enzyme CYP24A1. TGF-β1 alone decreased the number of secretory club and goblet cells and reduced the expression of constitutive host defense mediators SLPI, s/lPLUNC and pIgR, effects that were not modulated by VD. …”

AVP supplementation during hemorrhagic shock is associated with improved mitochondrial function. by Carrie A. Sims (4532332)

Liver histologic analysis. by Enio Rodrigues Vasques (2268448)

UNC2025 inhibits phosphorylation of MERTK in GBM cells leading to reduced cell number, colony-forming potential, and neurosphere diameter. by Alexandra Sufit (3270084)

Relative proportions of the most abundant classes change across a dissolved oxygen gradient and are significantly different when grouped by sampling depth. by Rachel L. Spietz (782905)

Liver histology. by Enio Rodrigues Vasques (2268448)

Molecular Origin of Photovoltaic Performance in Donor-<i>block</i>-Acceptor All-Conjugated Block Copolymers by Kendall A. Smith (1477033)

Molecular Origin of Photovoltaic Performance in Donor-<i>block</i>-Acceptor All-Conjugated Block Copolymers by Kendall A. Smith (1477033)

Molecular Origin of Photovoltaic Performance in Donor-<i>block</i>-Acceptor All-Conjugated Block Copolymers by Kendall A. Smith (1477033)

Molecular Origin of Photovoltaic Performance in Donor-<i>block</i>-Acceptor All-Conjugated Block Copolymers by Kendall A. Smith (1477033)

The global incidence of ZIKV infection in 204 countries and territories in 2019. by Zirui Guo (13994364)

Serum levels of inflammatory mediators. by Enio Rodrigues Vasques (2268448)

Aminotransferases four hours after liver reperfusion. by Enio Rodrigues Vasques (2268448)